Paul Ko

Paul Ko is an Associate Director at Johnson & Johnson in the Pharmaceutical Sector, specializing in Viral Vectors and Cell Therapies. With over 15 years of experience in bioprocess development and project management, Paul has contributed to significant advancements, including Johnson & Johnson's CAR-T Cell Therapies and viral vaccines. Paul holds a Ph.D. in Biomedical Engineering and a B.S. in Chemical Engineering, both from Carnegie Mellon University. Prior to their current role, Paul served as a Senior Scientist and Research Scientist at Johnson & Johnson, and worked as a Postdoc Researcher at the University of Pittsburgh.